We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
+4.12%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$2.02B
AUM Growth
+$1.3B
Cap. Flow
+$1.27B
Cap. Flow %
62.75%
Top 10 Hldgs %
16.65%
Holding
2,553
New
2,161
Increased
164
Reduced
123
Closed
87

Sector Composition

Rank Sector Weight
1 Financials 6.93%
2 Consumer Discretionary 6.9%
3 Healthcare 6.22%
4 Industrials 4.3%
5 Technology 4.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNXR
2326
DELISTED
Connecture, Inc.
CNXR
$24K ﹤0.01%
+35,481
New +$24.9K
DNN icon
2327
Denison Mines
DNN
$2.95B
$23K ﹤0.01%
+49,880
New +$23.5K
LTBR icon
2328
Lightbridge
LTBR
$292M
$23K ﹤0.01%
+1,706
New +$24K
TARA icon
2329
Protara Therapeutics
TARA
$231M
$23K ﹤0.01%
+293
New +$16.8K
EAGLW
2330
DELISTED
Double Eagle Acquisition Corp. Warrant
EAGLW
$23K ﹤0.01%
+33,656
New +$17.8K
CATX icon
2331
Perspective Therapeutics
CATX
$342M
$22K ﹤0.01%
+4,262
New +$23.9K
VTNR
2332
DELISTED
Vertex Energy, Inc
VTNR
$22K ﹤0.01%
+28,408
New +$26K
AAU
2333
DELISTED
Almaden Minerals Ltd
AAU
$22K ﹤0.01%
+19,007
New +$22.2K
KSPN
2334
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$22K ﹤0.01%
+538
New +$19.9K
ATIS
2335
DELISTED
Attis Industries Inc. Common Stock
ATIS
$22K ﹤0.01%
+2,166
New +$23.3K
LINU
2336
DELISTED
LiNiu Technology Group Ordinary Shares
LINU
$22K ﹤0.01%
+20,440
New +$31.6K
NVIV
2337
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$22K ﹤0.01%
+1
New +$30.7K
AXN
2338
DELISTED
Aoxing Pharmaceutical Company Inc.
AXN
$22K ﹤0.01%
+138,411
New +$37.8K
BSTG
2339
DELISTED
Biostage, Inc. Common Stock
BSTG
$22K ﹤0.01%
+70,685
New +$28.3K
FWDI
2340
Forward Industries Inc
FWDI
$313M
$21K ﹤0.01%
+1,740
New +$19.4K
ALIM
2341
DELISTED
Alimera Sciences
ALIM
$21K ﹤0.01%
+1,037
New +$22.2K
CGRN
2342
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$21K ﹤0.01%
+2,991
New +$19.3K
KGJI
2343
DELISTED
Kingold Jewelry Inc.
KGJI
$21K ﹤0.01%
+1,740
New +$17.9K
VRML
2344
DELISTED
Vermillion, Inc.
VRML
$21K ﹤0.01%
+11,416
New +$16.8K
DRRX
2345
DELISTED
DURECT Corp
DRRX
$20K ﹤0.01%
+1,108
New +$18.6K
GURE
2346
Gulf Resources
GURE
$4.71M
$20K ﹤0.01%
+206
New +$18.1K
JAGX icon
2347
Jaguar Health
JAGX
$4.1M
0
TMQ
2348
Trilogy Metals
TMQ
$670M
$20K ﹤0.01%
+21,303
New +$21.1K
ORKA
2349
Oruka Therapeutics
ORKA
$6.34B
$20K ﹤0.01%
+81
New +$28.8K
VIRX
2350
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$20K ﹤0.01%
+288
New +$23.5K

Similar funds

Virtu Financial's Q3 2017 Portfolio in Review

As of Q3 2017, Virtu Financial held 2,553 positions worth $2.02B, up 180% from $721M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Virtu Financial deployed $1.27B of net new capital in Q3 2017, opening 2,161 new positions and adding to 164 existing holdings. Its largest new stake was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.

By sector, the portfolio is most concentrated in Financials at 6.9% of assets, up from 5.8% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $24.8M trimmed.

  • Virtu Financial's largest Q3 2017 buy was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.
  • Virtu Financial added most to VanEck Gold Miners ETF in Q3 2017, an estimated $40.3M increase.
  • Virtu Financial's biggest Q3 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $24.8M.
  • Virtu Financial fully exited Oneok Partners LP in Q3 2017, selling an estimated $15.5M.
  • Virtu Financial's ten largest holdings make up 17% of its $2.02B portfolio in Q3 2017.
  • Virtu Financial opened 2,161 new positions and closed 87 in Q3 2017.
  • Virtu Financial's portfolio value rose 180% quarter-over-quarter to $2.02B.

Based on Virtu Financial's 13F filing for Q3 2017, filed 15 Nov 2017.